Market Cap 20.03B
Revenue (ttm) 3.25B
Net Income (ttm) -207.95M
EPS (ttm) N/A
PE Ratio 2,598.00
Forward PE 61.35
Profit Margin -6.40%
Debt to Equity Ratio 0.00
Volume 21,562,100
Avg Vol 2,640,294
Day's Range N/A - N/A
Shares Out 190.89M
Stochastic %K 96%
Beta 1.41
Analysts Sell
Price Target $101.44

Company Profile

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect Te...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 608 284 5700
Address:
5505 Endeavor Lane, Madison, United States
WycklyTrader
WycklyTrader Apr. 2 at 4:17 AM
KALV / PHVS potential big pharma acquisitions for hereditary angioedema (HAE) treatments. $APLS $DAWN $FOLD $EXAS $CNTA . BEP energy play.
0 · Reply
CromieAds
CromieAds Apr. 1 at 1:46 PM
0 · Reply
CromieAds
CromieAds Mar. 31 at 11:44 PM
$CAI should run up nicely tomorrow. This is big news!… https://www.prnewswire.com/news-releases/caris-life-sciences-finalizes-achieve-1-study-results-reinforcing-the-superior-sensitivity-and-specificity-of-caris-detect-302730659.html $EXAS $GH $GRAL
1 · Reply
thingkfast
thingkfast Mar. 27 at 1:33 PM
$EXAS well I’m officially taking EXAS off my watchlist, what a ride it has been. Our flagship products are now in the hands of Abbott with worldwide reach and exposure!! It was great talking to everyone. Remember Freenome is going public under FRNM in the first half of this year!! Good luck to all
0 · Reply
julianjakobi
julianjakobi Mar. 25 at 4:34 PM
Big congrats to everyone in $EXAS — insane run. A lot of us saw ~2000% gains, which honestly doesn’t happen often. I’ve personally rotated almost $ 1/2 Million of that into $BLGO. Different stage, but similar kind of setup in my opinion. Their Clyra Medical subsidiary is working on what could become a real game-changer in wound care with this copper-iodine tech. They’ve already locked in a deal with one of the top 4 medical companies, and from what I understand, products should hit the market this year once packaging clears. Manufacturing is ready for at least 2M units annually, so this isn’t some early concept anymore. The first product - ViaClyr - is just starting to roll out, and the bigger surgical push is expected later this year. Feels like one of those situations where the market hasn’t caught up yet. Definitely worth digging into if you’re looking for the next move post-EXAS. $EXAS $BLGO Check out what a woundcare specialist had to say in the photos attached.
3 · Reply
Easternbikes5
Easternbikes5 Mar. 25 at 1:23 PM
$EXAS guess my 4/17 calls for 105 are done. Originally seen the merger close in q2, $250 loss.
0 · Reply
FoolsInLove
FoolsInLove Mar. 25 at 3:26 AM
$EXAS im still waiting for the competitive bid from Pfizer…
0 · Reply
Gilgamesh
Gilgamesh Mar. 24 at 5:38 PM
$EXAS @Serafina1991 If you sella lot of $EXAS at a loss you can’t buy back within 30 days or you can’t take the tax loss. Buying a different biotech stock is not a problem-you can take the loss. Me lawyer.
0 · Reply
katico
katico Mar. 24 at 2:55 PM
$EXAS wash sales would be triggered by purchases of what the IRS considers **like-kind** investments. This means if you are selling EXAS (or any share lots within your EXAS overall investment) at a loss, and you want to avoid a wash sale, you should not purchase another biotech stock for 31 days after the EXAS sale. The same would apply to any biotech purchases made 30 days prior to the EXAS sale. Hope this helps!
1 · Reply
30DeltaSpy
30DeltaSpy Mar. 23 at 7:04 PM
$ABT + $EXAS Abbott closes $21B Exact Sciences deal https://www.chicagobusiness.com/health-care/ccb-abbott-exact-sciences-deal-closes/?utm_content=article8-headline&utm_source=afternoon-10&utm_medium=email&utm_campaign=20260323
0 · Reply
Latest News on EXAS
Exact Sciences Stockholders Approve Acquisition by Abbott

Feb 20, 2026, 4:05 PM EST - 6 weeks ago

Exact Sciences Stockholders Approve Acquisition by Abbott

ABT


Top 2 Health Care Stocks That May Crash In Q1

Jan 2, 2026, 8:58 AM EST - 3 months ago

Top 2 Health Care Stocks That May Crash In Q1

TEVA


Top 2 Health Care Stocks You May Want To Dump This Month

Dec 2, 2025, 9:01 AM EST - 4 months ago

Top 2 Health Care Stocks You May Want To Dump This Month

HAE


Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 4 months ago

Abbott to Acquire Exact Sciences for $21 Billion

ABT


Exact Sciences to Participate in November Investor Conference

Nov 4, 2025, 7:00 AM EST - 5 months ago

Exact Sciences to Participate in November Investor Conference


Exact Sciences Announces Third Quarter 2025 Results

Nov 3, 2025, 4:05 PM EST - 5 months ago

Exact Sciences Announces Third Quarter 2025 Results


Exact Sciences Schedules Third Quarter 2025 Earnings Call

Oct 8, 2025, 7:00 AM EDT - 6 months ago

Exact Sciences Schedules Third Quarter 2025 Earnings Call


Exact Sciences CEO on Launch of Multi-Cancer Blood Test

Sep 15, 2025, 3:30 PM EDT - 7 months ago

Exact Sciences CEO on Launch of Multi-Cancer Blood Test


Exact Sciences to Participate in September Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 8 months ago

Exact Sciences to Participate in September Investor Conferences


Exact Sciences Announces Second Quarter 2025 Results

Aug 6, 2025, 4:05 PM EDT - 8 months ago

Exact Sciences Announces Second Quarter 2025 Results


Exact Sciences Schedules Second Quarter 2025 Earnings Call

Jul 14, 2025, 6:00 AM EDT - 9 months ago

Exact Sciences Schedules Second Quarter 2025 Earnings Call


WycklyTrader
WycklyTrader Apr. 2 at 4:17 AM
KALV / PHVS potential big pharma acquisitions for hereditary angioedema (HAE) treatments. $APLS $DAWN $FOLD $EXAS $CNTA . BEP energy play.
0 · Reply
CromieAds
CromieAds Apr. 1 at 1:46 PM
0 · Reply
CromieAds
CromieAds Mar. 31 at 11:44 PM
$CAI should run up nicely tomorrow. This is big news!… https://www.prnewswire.com/news-releases/caris-life-sciences-finalizes-achieve-1-study-results-reinforcing-the-superior-sensitivity-and-specificity-of-caris-detect-302730659.html $EXAS $GH $GRAL
1 · Reply
thingkfast
thingkfast Mar. 27 at 1:33 PM
$EXAS well I’m officially taking EXAS off my watchlist, what a ride it has been. Our flagship products are now in the hands of Abbott with worldwide reach and exposure!! It was great talking to everyone. Remember Freenome is going public under FRNM in the first half of this year!! Good luck to all
0 · Reply
julianjakobi
julianjakobi Mar. 25 at 4:34 PM
Big congrats to everyone in $EXAS — insane run. A lot of us saw ~2000% gains, which honestly doesn’t happen often. I’ve personally rotated almost $ 1/2 Million of that into $BLGO. Different stage, but similar kind of setup in my opinion. Their Clyra Medical subsidiary is working on what could become a real game-changer in wound care with this copper-iodine tech. They’ve already locked in a deal with one of the top 4 medical companies, and from what I understand, products should hit the market this year once packaging clears. Manufacturing is ready for at least 2M units annually, so this isn’t some early concept anymore. The first product - ViaClyr - is just starting to roll out, and the bigger surgical push is expected later this year. Feels like one of those situations where the market hasn’t caught up yet. Definitely worth digging into if you’re looking for the next move post-EXAS. $EXAS $BLGO Check out what a woundcare specialist had to say in the photos attached.
3 · Reply
Easternbikes5
Easternbikes5 Mar. 25 at 1:23 PM
$EXAS guess my 4/17 calls for 105 are done. Originally seen the merger close in q2, $250 loss.
0 · Reply
FoolsInLove
FoolsInLove Mar. 25 at 3:26 AM
$EXAS im still waiting for the competitive bid from Pfizer…
0 · Reply
Gilgamesh
Gilgamesh Mar. 24 at 5:38 PM
$EXAS @Serafina1991 If you sella lot of $EXAS at a loss you can’t buy back within 30 days or you can’t take the tax loss. Buying a different biotech stock is not a problem-you can take the loss. Me lawyer.
0 · Reply
katico
katico Mar. 24 at 2:55 PM
$EXAS wash sales would be triggered by purchases of what the IRS considers **like-kind** investments. This means if you are selling EXAS (or any share lots within your EXAS overall investment) at a loss, and you want to avoid a wash sale, you should not purchase another biotech stock for 31 days after the EXAS sale. The same would apply to any biotech purchases made 30 days prior to the EXAS sale. Hope this helps!
1 · Reply
30DeltaSpy
30DeltaSpy Mar. 23 at 7:04 PM
$ABT + $EXAS Abbott closes $21B Exact Sciences deal https://www.chicagobusiness.com/health-care/ccb-abbott-exact-sciences-deal-closes/?utm_content=article8-headline&utm_source=afternoon-10&utm_medium=email&utm_campaign=20260323
0 · Reply
Serafina1991
Serafina1991 Mar. 23 at 6:07 PM
$EXAS I would love to hear from other EXAS Investors who will have all of their shares purchased today/tomorrow. Overall, I will be seeing a nice long term gain but there are some lots (long loss) pockets that will be offsetting some of those profits. Will those losses within my overall profit from EXAS shares be considered a basis for a wash sale should I decide to purchase another Biotech's shares within 31 days? I know that Is how It usually works but I AM realizing an overall profit from the sale of all of my EXAS shares and It IS a buyout. Thanks for the anticipated discussion
2 · Reply
bearcreekzeke
bearcreekzeke Mar. 23 at 4:58 PM
$EXAS Farewell and best of luck to you all my friends! One last Reddit post for you all. Please feel free to stop by and leave a comment - https://www.reddit.com/r/exactsciences/comments/1s1mbwy/exact_sciences_is_now_abbott/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
0 · Reply
bearcreekzeke
bearcreekzeke Mar. 23 at 4:55 PM
$EXAS For old time's sake: https://youtu.be/J2hI3-KvYZY?si=61TDSgT_-kAQQzV0
0 · Reply
Gilgamesh
Gilgamesh Mar. 23 at 3:17 PM
$EXAS Anyone get their money yet? Still waiting.
1 · Reply
Pavie99
Pavie99 Mar. 20 at 10:50 PM
$EXAS Contributed to this companys success for a few years. Loved following this thread over the years and proud of what we built. Exact was hands down the BEST company I have ever worked for. Fair, firm and results driven while always keeping the patient first! Congratulations to all longs.
0 · Reply
RunnerSignals
RunnerSignals Mar. 20 at 7:26 PM
Today 52-Week High $PL $XOM $OXY $CVX $EXAS
0 · Reply
TwongStocks
TwongStocks Mar. 20 at 6:20 PM
$EXAS Equity Corporate Actions Alert #2026 - 178 Information Regarding the Merger of Exact Sciences Corporation (EXAS) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-178 At a special meeting held on February 20, 2026, the shareholders of Exact Sciences Corporation (EXAS) approved the proposed merger with and into Abbott Laboratories (NYSE: ABT). The merger is tentatively scheduled to close prior to the market open on March 23, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on March 20, 2026. If the merger closes as anticipated, the stock will remain halted on the day of closing (March 23rd) and will be suspended effective March 24, 2026. EXAS shareholders will receive $105 per share at closing.
0 · Reply
KappaKeepoKuppo
KappaKeepoKuppo Mar. 20 at 1:52 PM
$EXAS Acquisition is officially closing on 23rd of March 2026. Godspeed to you all and see you on other ticker boards
1 · Reply
SaltWaterChickens
SaltWaterChickens Mar. 20 at 1:41 PM
$EXAS bingo
0 · Reply
julianjakobi
julianjakobi Mar. 11 at 4:50 PM
$EXAS Can any of my doctor / medical expert friends look into this please and give their honest feedback?‘ Is this the new gold standard in wound are? It is launching as we speak.. $BLGO Today!! https://www.linkedin.com/posts/advanced-solution717_were-excited-to-introduce-viaclyr-with-activity-7437135335341543425-4btU?utm_source=li_share&utm_content=feedcontent&utm_medium=g_dt_web&utm_campaign=copy
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 10 at 12:57 PM
$EXAS RSI: 63.89, MACD: 0.3724 Vol: 0.11, MA20: 103.37, MA50: 102.65 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Enjoy_Life_Bro
Enjoy_Life_Bro Mar. 9 at 9:30 PM
$EXAS Any news what is happening to Madison location once Kevin finishes his normal sell out? Everyone had to know this is what he planned all along
1 · Reply